Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biologic therapies in pediatric psoriasis: A single-center experience.

Archivos argentinos de pediatria·2026
Same author

Bridging the gap between the clinical need and drug approval in paediatric auto immune blistering diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Recurrent Toxin-Mediated Perineal Erythema: Eleven Pediatric Cases.

Pediatric dermatology·2026
Same author

Real-World Experience of Dupilumab in Children and Adolescents With Atopic Dermatitis in Argentina.

Pediatric dermatology·2026
Same author

Acneiform rash secondary to trametinib in two patients with neurofibromatosis.

Anais brasileiros de dermatologia·2025
Same author

Pseudo oculomotor palsy associated with Parry-Romberg syndrome.

Archivos argentinos de pediatria·2025
Same journal

Correlation between invasion front and survival of patients with cutaneous melanomas.

Anais brasileiros de dermatologia·2026
Same journal

Nanocarriers for topical minoxidil in androgenetic alopecia: systematic review of preclinical and clinical evidence.

Anais brasileiros de dermatologia·2026
Same journal

Pediatric psoriasis: from immunogenetics to targeted therapies.

Anais brasileiros de dermatologia·2026
Same journal

Perifollicular fibrosis and inflammation in androgenetic alopecia and seborrheic dermatitis: diagnostic challenges in differentiation from fibrosing alopecia in a pattern distribution.

Anais brasileiros de dermatologia·2026
Same journal

Exuberant cutaneous lymphoepithelioma-like carcinoma: clinicopathological correlation in an aggressive case<sup>⋆</sup>.

Anais brasileiros de dermatologia·2026
Same journal

Tumor-like periungual cutaneous sporotrichosis in an endemic area.

Anais brasileiros de dermatologia·2026
See all related articles

Related Experiment Video

Updated: Jun 19, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

[Fabry disease].

Paula Boggio1, Paula Carolina Luna, María Eugenia Abad

  • 1Departamento de Dermatologia, Hospital General de Agudos J.M. Ramos Mejía, Buenos Aires, Argentina. paulaboggio@fibertel.com.ar

Anais Brasileiros De Dermatologia
|October 24, 2009
PubMed
Summary
This summary is machine-generated.

Fabry disease, an X-linked disorder, results from a-galactosidase A deficiency, causing globotriaosylceramide buildup. Early signs like angiokeratomas and hypohidrosis are crucial for diagnosis and multidisciplinary care.

More Related Videos

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Related Experiment Videos

Last Updated: Jun 19, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
10:28

Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders

Published on: April 3, 2021

Area of Science:

  • Genetics and rare diseases
  • Biochemistry and metabolic disorders
  • Vascular and organ pathology

Context:

  • Fabry disease is an uncommon X-linked lysosomal storage disorder.
  • It stems from a partial or complete deficiency of the enzyme a-galactosidase A.
  • This deficiency leads to the accumulation of uncleaved globotriaosylceramide.

Purpose:

  • To review the literature on Fabry disease.
  • To highlight key diagnostic signs for early recognition.
  • To emphasize the importance of multidisciplinary assessment.

Summary:

  • The accumulation of globotriaosylceramide primarily affects vascular endothelium and visceral tissues, including skin, heart, kidneys, and the central nervous system.
  • Early identification of angiokeratomas and hypohidrosis are critical diagnostic indicators.
  • A comprehensive, multidisciplinary approach is essential for managing patients with Fabry disease.

Impact:

  • Facilitates earlier diagnosis and intervention for Fabry disease.
  • Improves patient outcomes through timely and coordinated care.
  • Enhances understanding of the clinical manifestations and diagnostic challenges.